research
-
An expert's opinion: Interview with Dr Pablo Moral on the fight against antimicrobial resistance
Dr Pablo Moral is a bioscientist working at GSK Global Health Medicines. As the industrial lead of the EU-funded END2AMR project, a European consortium launched in 2026 to pioneer novel therapies against drug-resistant pathogens, Dr. Moral stands at the forefront of the fight against antimicrobial resistance,... -
An expert’s opinion: Interview with Prof. Ron Boschma on Europe’s science and R&I performance
According to Ron Boschma, Professor in Regional Economics at Utrecht University, a place-based approach in future European R&I policy is important. He authored a chapter on this topic in the biennial 2026 Science, Research and Innovation Performance of the EU (SRIP) report. At the report's launch event... -
Putting science, research and innovation at the heart of Europe’s economic growth
According to the latest Science, Research and Innovation Performance of the EU (SRIP) report, Europe's excellence in science remains undisputed, but the EU underperforms when it comes to translating research into economic productivity. The report gives advice on how to tackle these and other challenges.... -
An expert's opinion: Interview with Samuel Greiff on new challenges in media and information literacy
In the run-up to the Global Media and Information Literacy Week, taking place from 24 to 31 October 2026, we speak with Prof. Dr Samuel Greiff, Professor of Educational Monitoring & Effectiveness at the Technical University of Munich. He leads the Centre for International Student Assessment and oversees... -
Can intellectual property and open science go together? Interview with Gustav Nilsonne
Open science and intellectual property are often framed as pulling in opposite directions: one built on free dissemination of knowledge, the other on protecting and rewarding innovation through exclusive rights. But as the pace of scientific publishing accelerates and generative AI reshapes how research... -
Phage therapy: From last resort to routine medicine
Ever more often, bacteria, viruses, fungi and parasites stop responding to the medicines designed to treat them, such as antibiotics. This antimicrobial resistance (AMR) poses a growing threat, with an estimated 8.22 million deaths globally in 2050. Armed conflicts are escalating the situation: conflicts... -
Interview with Prof. Naomi Ellemers about European challenges regarding advanced materials
To manufacture innovative high-tech and sustainable products, advanced materials play a key role. In response to their growing importance, the European Commission requested scientific advice on how Europe can strengthen its position in this field. The resulting report concludes that while Europe has... -
Shaping the future of open science in Europe: ‘Generative AI is transforming scientific exchange’
“Open science represents modern knowledge creation, but also supports evidence-based decision-making,” explains Prof. Dr. Julia Priess-Buchheit, professor at Kiel University with expertise in higher education, research integrity and open science. Open science also affects scientific exchange, that is,...